Certis can provide a variety of endpoints, including tumor volume measurements (TVM), growth curves, cell population characterization, phenotypic analysis, histological analysis and enzyme-linked immunoassay (ELISA).

Common endpoint analysis includes Homogeneous Time-Resolved Fluorescence (HTRF), Meso Scale Discovery (MSD^®), and spectral flow cytometry. Learn more about Certis’ preclinical services.